The investment-grade notes are due 2027

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by Illumina, Inc. of $500 million aggregate principal amount of 5.800% notes due 2025 and $500 million aggregate principal amount of 5.750% notes due 2027.

Illumina is a global leader in sequencing- and array-based solutions for genetic and genomic analysis. The company’s products and services serve customers in a wide range of markets, enabling the adoption of genomic solutions in research and clinical settings.

The Davis Polk capital markets team included partner Alan F. Denenberg and associates Georgina Green, Michelle Zhang and Rebecca Lei. Partner Mario J. Verdolini and associate Benjamin Helfgott provided tax advice. Partner David R. Bauer and associate Alison T. Chin provided intellectual property advice. Counsel Sarah E. Kim and associate Caroline R. Zhang provided 1940 Act advice. Members of the Davis Polk team are based in the Northern California and New York offices.